Healthcare's $110B AI Surge Is Picking Up Speed--and It's Just the Beginning

Issued on behalf of Avant Technologies Inc.

VANCOUVER, BC, July 8, 2025 /PRNewswire/ -- As artificial intelligence reshapes the future of medicine, understanding how patients actually feel about it is becoming just as critical as the technology itself. A new study published in Nature introduced an "AI Affinity Score" to measure patient comfort with AI in clinical settings—showing that education level and region heavily influence acceptance. The findings suggest that personalizing AI integration based on patient attitudes can enhance care quality and satisfaction. That kind of insight is already guiding investor attention toward emerging opportunities in a sector projected to surpass $110 billion by 2030, with companies like Avant Technologies, Inc. (OTCQB: AVAI), GE Healthcare Technologies Inc. (NASDAQ: GEHC), Waystar Holding Corp. (NASDAQ: WAY), The Cigna Group (NYSE: CI), and IQVIA Holdings Inc. (NYSE: IQV).